Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | 150,000 | reported | 12 May 2023 | tx 23+333,337−51,885 |
| ArriVent BioPharma, Inc. | 140,000 | reported | 02 Feb 2026 | tx 2+260,000 |
| Corbus Pharmaceuticals Holdings, Inc. | 12,300 | reported | 19 May 2026 | tx 6+48,032 |
| Janux Therapeutics, Inc. | 11,667 | reported | 11 Jun 2025 | tx 7+78,142 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 3,800 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 12,300 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | ArriVent BioPharma, Inc. | 140,000 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 4,800 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 16,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | ArriVent BioPharma, Inc. | 120,000 | 0.00 USD | deriv |
| 16 Aug 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 5,566 | 0.00 USD | |
| 16 Aug 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 5,566 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 12 May 2023 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 150,000 | 0.00 USD | deriv |
| 25 Nov 2022 | GIFT | PMV Pharmaceuticals, Inc. | 2,560 | 0.00 USD | |
| 21 Sept 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 21 Sept 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 9,375 | 0.00 USD | deriv |
| 20 Apr 2022 | EXERCISE | PMV Pharmaceuticals, Inc. | 4,000 | 3.22 USD | |
| 20 Apr 2022 | EXERCISE | PMV Pharmaceuticals, Inc. | 4,000 | 0.00 USD | deriv |
| 10 Feb 2022 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 104,400 | 0.00 USD | deriv |
| 30 Dec 2021 | GIFT | PMV Pharmaceuticals, Inc. | 2,725 | 0.00 USD | |
| 19 Aug 2021 | EXERCISE | PMV Pharmaceuticals, Inc. | 5,000 | 3.22 USD | |
| 19 Aug 2021 | EXERCISE | PMV Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 03 Aug 2021 | EXERCISE | PMV Pharmaceuticals, Inc. | 4,500 | 3.22 USD | |
| 03 Aug 2021 | SALE | PMV Pharmaceuticals, Inc. | 4,500 | 33.82 USD |